jueves, 2 de octubre de 2014

CT with Sigmoid Volvulus

HERE ►

CT with Sigmoid Volvulus



Univadis - un servicio de MSD

ACCEDA A IMÁGENES DE ALTA RESOLUCIÓN





CT with Sigmoid Volvulus

  • slide 6
  • video 1

EHMTIC: The impact of adverse childhood experiences on chronic daily headache

EHMTIC: The impact of adverse childhood experiences on chronic daily headache

Univadis - un servicio de MSD



EHMTIC: The impact of adverse childhood experiences on chronic daily headache

  • RSi Communications
  • logo conference-reports
as presented at the 4th European Headache and Migraine Trust International Congress
According to data presented at EHMTIC, held in September in Copenhagen, adverse childhood experience seems to be more common in patients with chronic headache than in controls, and most common in patients with a poor response to withdrawal therapy. 
Investigators at Sorlandet Hospital Kristiansand, Kristiansand, Norway, administered a questionnaire concerning Adverse Childhood Events (ACE) to patients who had participated in an earlier headache study, including patients and controls without headache or other chronic pain. 
Sixty-six patients (73% women) and 69 controls (70%  women) were included. Total ACE score was higher in patients (1.6) than in controls (0.9, P=0.02). Reporting sexual violation was more common in patients without improvement of headache (9/24 [38%]) than in controls (7/69 [10%], P <0.01). An ACE score >4 was more common in patients who did not improve (7/24 [29%]) than in patients who had improved more than 50% (1/21[5%], P=0.05), and more common than in controls (8/69 [12%],P=0.04).

Artículos relacionados

Mas Reportes de Congresos
EHMTIC: The impact of adverse childhood experiences on chronic daily headache
ESVS: Treatment of aortic prosthesis infections with graft removal and in situ replacement with autologous femoral veins
EASD: Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 2 diabetes
ESMO: Primary tumor location as a prognostic and predictive factor in advanced colorectal cancer
EASD: Diabetic peripheral neuropathy renders patients more likely to sway during stair climbing, and thus more likely to fall
EASD: 'Vintage' vegetables improve the health status of patients with type 2 diabetes when compared to equivalent modern vegetables
EASD: Oxford and Cambridge announce large multicenter trial of risks and benefits of metformin
EHMTIC: Pain less severe but more disabling in chronic vs frequent migraine patients
EASD: Users of insulin pumps at 29% reduced mortality compared with patients on insulin injections

ESVS: Short-term outcome of spinal cord ischemia after endovascular repair of thoracoabdominal aortic aneurysm

ESVS: Short-term outcome of spinal cord ischemia after endovascular repair of thoracoabdominal aortic aneurysm



Univadis - un servicio de MSD

ESVS: Short-term outcome of spinal cord ischemia after endovascular repair of thoracoabdominal aortic aneurysm

  • RSi Communications
  • logo conference-reports


as presented at the Annual Meeting of the European Society for Vascular Surgery
While the endovascular repair (ER) of thoracoabdominal aortic aneurysm (TAAA) has low perioperative mortality compared to contemporary open repair, the incidence of spinal cord ischemia is high. 
At ESVS, held in September in Stockholm, scientists from the Vascular Center in Malmo, Sweden, presented their retrospective review of patient charts, pre-, intra-, and post-operative imaging, and other variables for all patients undergoing ER with branched stent grafts for Crawford class I-IV TAAA between 2008 and 2013. 
Sixty-five patients (49 males) were included in the analysis; 45 underwent elective repair, 20 acute. The patients were grouped anatomically according to Crawford class: 11 type I, 25 type II, 15 type III, and 14 type IV. The 30-day mortality was 7.7% (two elective and three ruptures, including one intraoperative death). Twenty-one patients (33%) developed SCI: two type I (20%), 13 type II (52%), three type III (20 %), and three type IV (21%). 
According to the researchers, after the perioperative period, 14 patients had total (n=5) or partial (n=9) recovery from SCI. Some permanent SCI deficit beyond 30 days (n=15, 25%) was more common for type II TAAA (P=0.06); elective patients (P=0.046); longer operative time (P=0.028); more bleeding (P=0.041); and higher contrast volume use (P=0.022). All patients with permanent SCI had received spinal drainage. 
“Further analysis is required on the predictive factors of SCI,” the investigators concluded. “Improved patient selection and better [perioperative] and operative management might improve outcomes.”  

Artículos relacionados




Laboratory Tests Update

Laboratory Tests Update



Laboratory Tests Update

New on the MedlinePlus Laboratory Tests page:
09/28/2014 02:00 PM EDT

Finding might lead one day to test for a disease that's hard to detect before advanced stages
HealthDay news image

Source: HealthDay
09/25/2014 04:00 PM EDT

Study provides insight into schizophrenia
HealthDay news image

Source: HealthDay
09/24/2014 02:00 PM EDT

Activity of some white blood cells may provide clues to healing time
HealthDay news image

Source: HealthDay

Climate Change Update

Climate Change Update



Climate Change Update

New on the MedlinePlus Climate Change page:
09/29/2014 10:30 AM EDT

Source: National Library of Medicine - NIH
09/29/2014 09:19 AM EDT

Source: National Library of Medicine - NIH
09/27/2014 06:42 PM EDT

Source: U.S. Global Change Research Program
09/27/2014 06:42 PM EDT

Source: World Health Organization

Statins Update

Statins Update



Statins Update

New on the MedlinePlus Statins page:
09/30/2014 10:54 AM EDT

Source: American College of Physicians - PDF

Deep Vein Thrombosis Update

Deep Vein Thrombosis Update



Deep Vein Thrombosis Update

New on the MedlinePlus Deep Vein Thrombosis page:
09/30/2014 08:25 AM EDT

Source: Vascular Disease Foundation - PDF
09/30/2014 08:25 AM EDT

Source: American College of Emergency Physicians
09/24/2014 07:00 PM EDT

NSAID medicines include aspirin, ibuprofen and naproxen/Aleve
HealthDay news image

Source: HealthDay